切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2022, Vol. 15 ›› Issue (02) : 141 -145. doi: 10.3877/cma.j.issn.1674-6902.2022.02.001

论著

mmu_circ_0001033过表达慢病毒载体的构建与鉴定
黄朝旺1, 韦雅琴2, 许发琼3, 徐康乔2, 胡巧4, 张静4, 夏世金2,(), 胡明冬4,()   
  1. 1. 400037 重庆,陆军(第三)军医大学第二附属医院老年与特勤医学科;400037 重庆,陆军(第三)军医大学第二附属医院呼吸与危重症医学中心
    2. 200040 上海,复旦大学附属华东医院上海市老年医学研究所
    3. 400037 重庆,陆军(第三)军医大学第二附属医院呼吸与危重症医学中心
    4. 400037 重庆,陆军(第三)军医大学第二附属医院老年与特勤医学科
  • 收稿日期:2021-06-28 出版日期:2022-04-25
  • 通信作者: 夏世金, 胡明冬
  • 基金资助:
    国家自然科学基金面上项目(81870044,81873421); 高校基础研究课题(2020-2017-075)

Construction and identification of mmu_circ_0001033 overexpression lentiviral vector

Chaowang Huang1, Yaqin Wei2, Faqiong Xu3, Kangqiao Xu2, Qiao Hu4, Jing Zhang4, Shijin Xia2,(), Mingdong Hu4,()   

  1. 1. Department of Geriatrics and Special Services Medicine, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China; Institute of Respiratory Diseases, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
    2. Institute of Gerontology, Huadong Hospital, Fudan University, Shanghai 200040, China
    3. Institute of Respiratory Diseases, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
    4. Department of Geriatrics and Special Services Medicine, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
  • Received:2021-06-28 Published:2022-04-25
  • Corresponding author: Shijin Xia, Mingdong Hu
引用本文:

黄朝旺, 韦雅琴, 许发琼, 徐康乔, 胡巧, 张静, 夏世金, 胡明冬. mmu_circ_0001033过表达慢病毒载体的构建与鉴定[J]. 中华肺部疾病杂志(电子版), 2022, 15(02): 141-145.

Chaowang Huang, Yaqin Wei, Faqiong Xu, Kangqiao Xu, Qiao Hu, Jing Zhang, Shijin Xia, Mingdong Hu. Construction and identification of mmu_circ_0001033 overexpression lentiviral vector[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2022, 15(02): 141-145.

目的

构建环状RNA mmu_circ_0001033慢病毒表达载体,作为在低氧性肺动脉高压功能学实验研究的基础。

方法

首先设计引物将目的基因片段从原质粒上扩增下来,通过引物两端所含无缝克隆识别位点将其重组到酶切后的过表达载体上;将连接产物转入制备好的细菌感受态细胞,而后将其单克隆菌落送测序公司进行测序鉴定。其次通过PCR产物跑胶和测序验证成环情况。最后用构建的重组表达载体和包装质粒共同转染293T细胞,包装慢病毒,收集病毒原液,超滤浓缩,并测定滴度。

结果

经过比对,重组克隆中插入片段序列与目的片段序列完全一致,表明质粒构建成功。PCR产物后经sanger测序确认环化位点处序列完全正确。将构建的过表达载体测序结果和质粒构建方案基因比对,重组克隆中插入片段序列与目的片段序列与预期完全一致,可实现转染质粒后目的基因的表达,PCR产物跑胶和测序结果表明mmu_circ_0001033成环成功。PCR产物跑胶和测序结果表明mmu_circ_0001033成环成功。最后通过比较RT-qPCR测定病毒滴度值为2.09×108 TU/ml。

结论

成功构建环状RNA mmu_circ_0001033慢病毒表达载体,能稳定转染293T细胞,可用于后续细胞实验。

Objective

Construction of the mmu_circ_0001033 lentiviral expression vector as the basis for the study of its functional experimental study in hypoxic pulmonary hypertension.

Methods

First, primers were designed to amplify the target gene fragment from the original plasmid, and recombined it into the overexpression vector after digestion through the seamless clone recognition sites contained at both ends of the primer, transferred the ligation product into the prepared bacterial sensation Then sent its monoclonal colony to a sequencing company for sequencing and identification. The looping condition was verified by running the gel and sequencing the PCR product. Finally, the constructed recombinant expression vector and packaging plasmid were used to co-transfect 293T cells, packaged the lentivirus, collected the virus stock, concentrated by ultrafiltration, and determined the titer.

Results

The sequence of the inserted fragment in the recombinant clone was exactly the same as the sequence of the target fragment, indicating that the plasmid was constructed successfully. The PCR product was confirmed by sanger sequencing to confirm the correct sequence at the cyclarization site. By comparing the sequencing results of the constructed overexpression vector and the plasmid construction scheme, the insert sequence and the target fragment sequence in the recombinant clone are exactly as expected, which can realize the expression of the target gene after transfection of the plasmid, the PCR product running gel and sequencing results showed that mmu_circ_0001033 was successfully looped, the PCR product running gel and sequencing results showed that mmu_circ_0001033 was successfully looped. Finally, the virus titer value determined by RT-qPCR was 2.09×108 TU/ml.

Conclusion

The mmu_circ_0001033 lentiviral expression vector was successfully constructed, which can stably transfect 293T cells and can be used for subsequent cell experiments.

表1 引物序列
图1 重组质粒结构图
表2 目的基因的检测用引物序列(5′-3′)
图2 重组慢病毒测序结果
图3 PCR验证成环示意图;注:泳道1︰2 000 Marker;泳道2: NC (C-primers);泳道3: RC (C-primers);泳道4: OE (C-primers);泳道5: NC (D-primers);泳道6: RC (D-primers);泳道7: OE (D-primers);泳道8: ACTB-空细胞;泳道9: ACTB-非成环;泳道10: ACTB-成环
1
Norbert FV, Rubin MT. Hypoxia-induced pulmonary vascular remodeling:a model for what human disease?[J]. J Clin investigation, 2000, 106(6): 733-738.
2
Larissa AS, Steven SL. Vascular remodeling in pulmonary hypertension[J]. J Mol Med (Berlin Germany), 2013, 91(3): 297-309.
3
Marius MH, Hossein-Ardeschir G, Ekkehard G, et al. Pulmonary hypertension[J]. Deutsch Arztebl Int, 2017, 114(5): 73-84.
4
Hansmann G. Pulmonary hypertension in infants, children, and young adults[J]. J Am Coll Cardiol, 2017, 69(20): 2551-2569.
5
Devashis M, Girija GK. Pediatric pulmonary hypertension: Definitions, mechanisms, diagnosis, and treatment[J]. Comprehensive Physiology, 2021, 11(3): 2135-2190.
6
尹连红,杨悦悦,郑玲俐. 肺动脉高压发病机制及中药干预研究进展[J]. 辽宁中医药大学学报2022, 24(1): 213-220.
7
胡盼盼,孙增先,姜艳娇,等. 肺动脉高压发病机制的最新研究进展[J]. 重庆医学2022, 51(4): 678-682.
8
徐康乔,夏世金. 低氧性肺动脉高压发生机制与诊治新策略[J/CD]. 中华肺部疾病杂志(电子版), 2020, 13(2): 127-133.
9
Eleni A, Leni SJ, Frank JS. Non-coding RNA networks in cancer[J]. Nat Rev Cancer, 2018, 18(1): 5-18.
10
Michaël D, Manel E. Lung cancer epigenetics: From knowledge to applications[J]. Semin Cancer Biol, 2018, 51: 116-128.
11
Huang J, Peng J, Guo LL. Non-coding RNA: a new tool for the diagnosis, prognosis, and therapy of small cell lung cancer[J]. J Thorac Oncol, 2015, 10(1): 28-37.
12
Lasse SK, Theresa J, Henrik H, et al. The emerging roles of circRNAs in cancer and oncology[J]. Nat Rev Clin Oncol, 2022, 19(3): 188-206.
13
Deng L. LncPTSR triggers vascular remodeling in pulmonary hypertension by regulating [Ca2+]i in pulmonary arterial smooth muscle cells[J]. Am J Respir Cell Mol Biol, 2022. doi: 10.1165/rcmb.2020-0480OC.
14
Feng XN, Wang KF, Yang T, et al. LncRNA-GAS5/miR-382-3p axis inhibits pulmonary artery remodeling and promotes autophagy in chronic thromboembolic pulmonary hypertension[J]. Genes & Genomics, 2022.doi: 10.1007/s13258-021-01202-z
15
Susana CR, Lucía F, Edurne B, et al. MicroRNA nanotherapeutics for lung targeting. Insights into pulmonary hypertension [J]. Int J Mol Sci, 2020, 21(9): 3253.
16
Zhang JT, Li YY, Qi J, et al. calm4Circ-Serves as an sponge to regulate Myo10 (Myosin 10) and promote pulmonary artery smooth muscle proliferation[J]. Hypertension, 2020, 75(3): 668-679.
17
Xu SL, Deng YS, Liu J, et al. Regulation of circular RNAs act as ceRNA in a hypoxic pulmonary hypertension rat model [J]. Genomics, 2021, 113: 11-19.
18
Zhuo S, Jiang H, Li M, et al. Circular RNA hsa_circ_0016070 is associated with pulmonary arterial hypertension by promoting PASMC proliferation[J]. Molecular therapy, 2019, 18: 275-284.
19
Wang J, Zhu MC, Pan J, et al. Circular RNAs: a rising star in respiratory diseases[J]. Res Research, 2019, 20(3): 1-10.
20
Zhang JR, Sun HJ. MiRNAs, lncRNAs, and circular RNAs as mediators in hypertension-related vascular smooth muscle cell dysfunction[J]. Hypertension Res, 2021, 44(2): 129-146.
21
王灵霞,严玉兰,袁海涛,等. CircRNA_23113抑制肺腺癌细胞的增殖和迁移[J]. 基础医学与临床2022, 42(1): 82-88.
22
王 坚,胡明冬,唐晓丹,等. 慢病毒介导环状RNA mmu-circ-0001033过表达抑制低氧性小鼠肺动脉平滑肌细胞增殖的实验研究[J/CD]. 中华肺部疾病杂志(电子版), 2018, 11(1): 39-43.
23
Houghton BC, Booth C, Thrasher AJ. Lentivirus technologies for modulation of the immune system[J]. Curr Opin Pharmacology, 2015, 24: 119-127.
24
Douglas AR, Christopher PD, Adam VK, et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference[J]. Nature genetics, 2003, 33(3): 401-406.
[1] 纪文鑫, 王茂, 邱春丽, 李尚鹏, 代引海. 血清外泌体circ PVT1与circ 0014606在三阴性乳腺癌中的表达及临床意义[J]. 中华普外科手术学杂志(电子版), 2023, 17(03): 267-271.
[2] 张博, 韩威, 郝少龙, 李泽乾, 纪智礼. 竞争内源性RNA在胰腺癌研究中的进展[J]. 中华普外科手术学杂志(电子版), 2023, 17(02): 213-216.
[3] 吴丽娜, 魏林, 曾志贵, 张梁, 何恩辉, 檀玉乐, 朱志军, 孙丽莹. 肺动脉高压靶向药物联合肝移植治疗重度门脉性肺动脉高压一例[J]. 中华移植杂志(电子版), 2022, 16(06): 376-378.
[4] 王邦郁, 陈晓鹏, 唐国军, 王佳妮. 尿液细胞外囊泡circRNA分类器对高级别前列腺癌诊断价值的初步研究[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 339-342.
[5] 代芬, 卞士柱. 无创机械通气联合肺康复在肺动脉高压呼吸衰竭治疗中的临床应用[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 560-562.
[6] 李丹阳, 李满祥. 肠道菌群失调在肺动脉高压发病中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 432-434.
[7] 任成山, 卞士柱, 胡明冬. 肺动脉高压的成因及治疗新理念[J]. 中华肺部疾病杂志(电子版), 2023, 16(01): 1-5.
[8] 张璐, 卞士柱. 肺动脉高压患者药物治疗依从性及健康管理分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(01): 107-109.
[9] 代芬, 卞士柱. Ⅰ期心脏运动康复在肺动脉高压患者中的临床意义[J]. 中华肺部疾病杂志(电子版), 2022, 15(05): 721-723.
[10] 王楚风, 蒋安. 原发性肝癌的分子诊断[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 499-503.
[11] 范博洋, 王宁, 张骞, 王贵玉. 结直肠癌转移调控的环状RNA分子机制研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 426-430.
[12] 方蕊, 宋旭东. 非编码核糖核酸与白内障相关的研究进展[J]. 中华眼科医学杂志(电子版), 2023, 13(02): 94-98.
[13] 韩晓娟, 徐佳倩, 朱玉兰, 王莹, 李源, 冯珺, 邵东. HHLA2过表达胃癌细胞株构建及细胞功能的初步研究[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 373-377.
[14] 余林阳, 王美英, 李建斌, 楼骁斌, 谢思远, 马志忠, 齐海英, 李稼. 高原地区肺炎合并右心功能衰竭体征患儿的肺动脉压力和心脏形态与功能的特征[J]. 中华临床医师杂志(电子版), 2023, 17(05): 535-544.
[15] 王金志, 陶新曹, 谢万木, 傅志辉, 赵蕴伟, 黄强, 翟振国. 球囊肺动脉成形术在慢性血栓栓塞性肺动脉高压治疗中的进展[J]. 中华介入放射学电子杂志, 2023, 11(03): 262-267.
阅读次数
全文


摘要